Mumbai: OMD India, a part of Omnicom Media Group, has secured the integrated media mandate for Piramal Pharma’s consumer healthcare division following a competitive multi-round pitch. The agency will drive strategic marketing and media efforts to scale the brand with sharp, creative, and forward-thinking communication strategies.
As part of this collaboration, OMD India will oversee the media strategy for Piramal Pharma’s OTC portfolio, which includes well-known brands such as Lacto Calamine, Little’s, Tetmosol, Polycrol, and women’s intimate health products like i-pill and i-activ. The mandate will be managed out of OMD India’s Mumbai office.
Known for its expertise in media and digital innovation, OMD India will focus on enhancing Piramal Pharma’s market presence, increasing brand salience, driving consumer engagement, and executing impact-driven marketing strategies for business growth.
Expressing her enthusiasm about the partnership, Anisha Iyer, CEO of OMD India, stated, “We are excited to embark on this partnership with Piramal Consumer Healthcare, a company that mirrors our commitment to innovation and excellence. This collaboration presents a significant opportunity to leverage our strategic acumen and deep market intelligence to elevate Piramal’s impressive portfolio of brands to new heights. Together, we aim to craft media strategies that go beyond visibility—building lasting trust and loyalty with consumers across India and shaping a future of sustained growth and impact.”
With this partnership, OMD India continues to strengthen its leadership in the Indian media landscape, driving impactful marketing solutions for top-tier brands.
